Skip to main content
Year archive

CMG Pharmaceutical Co., Ltd. — 2025 filings

All 20 regulatory filings released by CMG Pharmaceutical Co., Ltd. (058820) in 2025, sourced directly from the official regulator.

20 Filings
2025 Period
2025 filings (20)
Filing Released Lang
[기재정정]신규시설투자등
Capital/Financing Update
2025-12-29 Korean
전환가액의조정
Capital/Financing Update
2025-09-11 Korean
반기보고서 (2025.06)
Interim / Quarterly Report H1 2025
2025-08-13 Korean
전환청구권행사
Share Issue/Capital Change
2025-06-25 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2025-06-09 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Q1 2025
2025-05-14 Korean
소속부변경
Regulatory Filings
2025-04-30 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2025-04-18 Korean
전환청구권행사
Share Issue/Capital Change
2025-04-18 Korean
투자판단관련주요경영사항 (메조피(Mezofy) 미국 식품의약국(FDA) 품목허가 획득)
Regulatory Filings
2025-04-16 Korean
[기재정정]신규시설투자등
Regulatory Filings
2025-04-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2025-03-28 Korean
사업보고서 (2024.12)
Audit Report / Information FY 2024
2025-03-20 Korean
감사보고서제출
Audit Report / Information FY 2024
2025-03-19 Korean
주주총회소집결의
AGM Information
2025-03-12 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2025-03-12 Korean
주주총회집중일개최사유신고
AGM Information
2025-03-12 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2025-02-13 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2024
2025-02-12 Korean
전환가액의조정
Share Issue/Capital Change
2025-02-11 Korean